Hunan Chengda Biotechnology Co., Ltd. is a wholly-owned subsidiary of xinhexin biomedical group, a private joint-stock listed enterprise, Guangdong Yiduoli Biotechnology Co., Ltd. (Stock Code: 300381). In 2011, the company was invested by Anhua government and settled in Malu Town, Anhua County. It has a registered capital of 50 million yuan, covers an area of 186 mu, a total construction area of 72000 square meters, fixed assets of 250 million yuan, and more than 200 employees. It is a high-tech enterprise mainly engaged in steroid hormone drug raw materials and intermediates, with an annual output value of more than 400 million yuan. A number of scientific research achievements have obtained national patents. After careful construction, it has been built into a modern garden factory.
Since 2017, the company has invested 50 million yuan to build a new GMP production line for veterinary drugs, gradually transforming into veterinary drug raw materials, preparations and deep-processing products of traditional Chinese medicine. In 2018, it obtained the veterinary drug production license and GMP certification certificate, and awarded the standing director of Hunan veterinary drug industry association.
According to GMP requirements and advanced EHS management concept, the company has basically formed a closed-loop industrial chain of R & D process, synthetic production and quality control management. We are committed to the research and application of biomedical technology, and excellent products and services to meet the needs of customers. With the posture of "based on Anhua and looking at the world", we make due contributions to human health and add luster to the national industry of the motherland.